Delivery Order SPE2DB22D1017-SPE2DB25FG4BH
- Not listed
- The Defense Logistics Agency awarded a $4,579.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of VENCLEXTA 100 mg tablets (120 count), valued at $9,728.17. This firm fixed-price, competitively awarded delivery order is expected to be completed by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 on June 16, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VENCLEXTA 100 MG TABLET UU 120S. The contract has a completion date of March 5, 2024 and a potential value of $17,760.30. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will supply the pharmaceutical product from its Corporate Office division...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on September 10, 2025, with completion targeted for October 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120-count units) valued at $9,728.17 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 6, 2025, and represents a delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4BHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for VENCLEXTA 100 MG tablets (120-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded on June 3, 2025, with an ultimate completion date of June 25, 2025. The award represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's performance location for this delivery order is its corporate office in Conshohocken, PA. Through its DLA contracts, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products spanning multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's ability to fulfill competitive federal procurement requirements across varying transaction values demonstrates its significant capacity to serve the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 6/3/25 |